Skip NavigationSkip to Content

NCI at Frederick Scientific Publications Advanced Search

Search

  1. NCI-F Publications

  2. Return to Quick Search
Search
  2. Year Published:

Your search returned 10 results.
User Information
Export Records
  1. 1.   Immunological monitoring of the tumor immunoenvironment for clinical trials
  2. Malyguine, A. M.; Strobl, S. L.; Shurin, M. R.
  3. Cancer Immunology Immunotherapy. 2012, Feb; 61(2): 239-247.
  1. 2.   Recommendations from the iSBTc-SITC/FDA/NCI Workshop on Immunotherapy Biomarkers
  2. Butterfield, L. H.; Palucka, A. K.; Britten, C. M.; Dhodapkar, M. V.; Hakansson, L.; Janetzki, S.; Kawakami, Y.; Kleen, T. O.; Lee, P. P.; Maccalli, C.; Maecker, H. T.; Maino, V. C.; Maio, M.; Malyguine, A.; Masucci, G.; Pawelec, G.; Potter, D. M.; Rivoltini, L.; Salazar, L. G.; Schendel, D. J.; Slingluff, C. L.; Song, W. R.; Stroncek, D. F.; Tahara, H.; Thurin, M.; Trinchieri, G.; van Der Burg, S. H.; Whiteside, T. L.; Wigginton, J. M.; Marincola, F.; Khleif, S.; Fox, B. A.; Disis, M. L.
  3. Clinical Cancer Research. 2011, May; 17(10): 3064-3076.
  1. 3.   New flow cytometric assays for monitoring cell-mediated cytotoxicity
  2. Zaritskaya, L.; Shurin, M. R.; Sayers, T. J.; Malyguine, A. M.
  3. Expert Review of Vaccines. 2010, Jun; 9(6): 601-616.
  1. 4.   New approaches for monitoring CTL activity in clinical trials
  2. Malyguine, A.; Strobl, S.; Zaritskaya, L.; Baseler, M.; Shafer-Weaver, K.
  3. Immune-Mediated Diseases: From Theory to Therapy. 2007; 601 : 273-284.
  1. 5.   A novel flow cytometric assay for evaluating cell-mediated cytotoxicity
  2. Burkett, M. W.; Weaver, K. A. S.; Strobl, S.; Baseler, M.; Malyguine, A.
  3. Journal of Immunotherapy. 2005, JUL-AUG; 28(4): 396-402.
  1. 6.   Dueling ELISPOTS: Use of the IFN-gamma, GrB, or dual color IFN-gamma/GrB ELISPOT assay for immunological monitoring
  2. Shafer-Weaver, K. A.; Zartiskaya, L.; Strobl, S.; Luck, T.; Baseler, M.; Malyguine, A.
  3. Journal of Immunotherapy. 2005, NOV-DEC; 28(6): 634-634.
  1. 7.   Optimization of a dendritic cell based whole protein ELISPOT assay for immunological monitoring
  2. Strobl, S. L.; Zaritskaya, L.; Shafer-Weaver, K.; Baseler, M.; Malyguine, A.
  3. Journal of Immunotherapy. 2005, NOV-DEC; 28(6): 634-635.
  1. 8.   Association of strong virus-specific CD4 T cell responses with efficient natural control of primary HIV-1 infection
  2. Gloster, S. E.; Newton, P.; Cornforth, D.; Lifson, J. D.; Williams, I.; Shaw, G. M.; Borrow, P.
  3. Aids. 2004 18(5): 749-755.
  1. 9.   The IFN-gamma and GrB elispot assays: Partners for monitoring clinical immune responses
  2. Shafer-Weaver, K.; Ulderich, T.; Strobl, S.; Baseler, M.; Malyguine, A.
  3. Journal of Immunotherapy. 2004, NOV-DEC; 27(6): S43-S43.
  1. 10.   Correlation of human CD56(+) cell cytotoxicity and IFN-gamma production
  2. Derby, E. G.; Reddy, V.; Nelson, E. L.; Kopp, W. C.; Baseler, M. W.; Dawson, J. R.; Malyguine, A. M.
  3. Cytokine. 2001 13(2): 85-90.
NCI at Frederick

You are leaving a government website.

This external link provides additional information that is consistent with the intended purpose of this site. The government cannot attest to the accuracy of a non-federal site.

Linking to a non-federal site does not constitute an endorsement by this institution or any of its employees of the sponsors or the information and products presented on the site. You will be subject to the destination site's privacy policy when you follow the link.

ContinueCancel